Lazertinib

ATC L01EB09 · 10 markets · 17 records

Lazertinib 10 markets · 17 records Forms

US 2 records · 2 strengths

GB 2 records · 2 strengths

CA 2 records · 2 strengths

SG 2 records · 2 strengths

ES 2 records · 2 strengths

TW 2 records · 2 strengths

  • 240 mgtabletLAZCLUZE力安莎膜衣錠240毫克 also in US·GB·CA +2
  • 80 mgtabletLAZCLUZE力安莎膜衣錠80毫克 also in US·GB·CA +2

HK 2 records · 1 strengths

    Records without a stated strength · 1 LAZCLUZE

    AU 1 records · 1 strengths

      Records without a stated strength · 1 LAZCLUZE

      MX 1 records · 1 strengths

        Records without a stated strength · 1 LAZCLUZE

        EU 1 records · 1 strengths

        EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

          Records without a stated strength · 1 LAZCLUZE

          Side-by-side table

          The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

          Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.